192 related articles for article (PubMed ID: 5081011)
1. The development of plasma derivatives in Switzerland.
Kistler P
Vox Sang; 1972; 23(1):26-31. PubMed ID: 5081011
[No Abstract] [Full Text] [Related]
2. Experiences in the development of plasma derivatives in Japan.
Naito R
Vox Sang; 1972; 23(1):35-7. PubMed ID: 4117047
[No Abstract] [Full Text] [Related]
3. The current status of blood fractionation in the United States.
Sgouris JT
Vox Sang; 1972; 23(1):45-55. PubMed ID: 5081014
[No Abstract] [Full Text] [Related]
4. The development of plasma derivatives in Canada.
McVicar GA
Vox Sang; 1972; 23(1):33-4. PubMed ID: 4117046
[No Abstract] [Full Text] [Related]
5. Plasma fractionation in England and Wales.
Vallet L
Vox Sang; 1972; 23(1):58-60. PubMed ID: 4628157
[No Abstract] [Full Text] [Related]
6. The development of plasma derivatives for clinical use. A symposium summary.
Deutsch HF
Vox Sang; 1972; 23(1):147-50. PubMed ID: 5081010
[No Abstract] [Full Text] [Related]
7. Notes on the development of plasma derivatives in the Netherlands.
Krijnen HW
Vox Sang; 1972; 23(1):32. PubMed ID: 5081012
[No Abstract] [Full Text] [Related]
8. Round table discussion on regulatory and other problems, including hepatitis, in the development of plasma derivatives.
Vox Sang; 1972; 23(1):72-9. PubMed ID: 5081017
[No Abstract] [Full Text] [Related]
9. Notes on plasma derivative production in the Federal Republic of Germany.
Schwick HG
Vox Sang; 1972; 23(1):44. PubMed ID: 5081013
[No Abstract] [Full Text] [Related]
10. Development of plasma derivatives for clinical use.
Tullis JL
Vox Sang; 1972; 23(1):3-9. PubMed ID: 4117048
[No Abstract] [Full Text] [Related]
11. [Plasmapheresis in normal donors ].
Frey-Wettstein M
Ther Umsch; 1982 Jul; 39(7):551-4. PubMed ID: 7123508
[No Abstract] [Full Text] [Related]
12. Round table discussion on plasma fractionation.
Vox Sang; 1972; 23(1):61-5. PubMed ID: 5081015
[No Abstract] [Full Text] [Related]
13. The development of plasma derivatives in Australia.
Schiff P
Vox Sang; 1972; 23(1):38-43. PubMed ID: 4628156
[No Abstract] [Full Text] [Related]
14. [Blood transfusion 1975].
Hässig A
Z Krankenpfl; 1975 Nov; 68(11):312-6. PubMed ID: 1043566
[No Abstract] [Full Text] [Related]
15. [50 years of blood transfusion services of the Swiss Red Cross].
Hässig A
Schweiz Med Wochenschr; 1991 Feb; 121(5):156-9. PubMed ID: 2003212
[TBL] [Abstract][Full Text] [Related]
16. Can a national all voluntary blood transfusion service by adequate blood component therapy cover actual and future needs of albumin?
Barker LF; Cazal P; Haussman HG; Hollán S; Kellner A; Lundsgaard-Hansen P; Schiff P
Vox Sang; 1976; 31?-73(3):225-38. PubMed ID: 969394
[No Abstract] [Full Text] [Related]
17. Plasma fractionation in the United States. A review for clinicians.
Ness PM; Pennington RM
JAMA; 1974 Oct; 230(2):247-50. PubMed ID: 4137885
[No Abstract] [Full Text] [Related]
18. Fractionation of plasma with polyethylene glycol.
Polson A; Ruiz-Bravo C
Vox Sang; 1972; 23(1):107-18. PubMed ID: 5081005
[No Abstract] [Full Text] [Related]
19. The provision of plasma for the derivatives program of the Swiss Red Cross blood transfusion service.
Hässig A
Haematologia (Budap); 1980; 13(1-4):169-73. PubMed ID: 7250810
[No Abstract] [Full Text] [Related]
20. [Transfusion medicine and blood donor services. The organization of the Blood Donor Service of the Swiss Red Cross].
Bucher H
Ther Umsch; 1984 Aug; 41(8):536-9. PubMed ID: 6495229
[No Abstract] [Full Text] [Related]
[Next] [New Search]
